Upper GI Tract
Latest News
Dupilumab for Eosinophilic Esophagitis: How Is it Improving Treatment?
Dupilumab has “really changed care in people with moderate to severe disease who are not responding or are intolerant to the other treatments,”...
Pearls from the Pros
The Paradox of Achalasia Symptoms
Reduction of symptoms of dysphagia lulls the gastroenterologist into thinking their patients are doing well.
Article
Commentary: PPI Dosing, Biomarkers, and Eating Behaviors in Patients With EoE, March 2024
From the AGA Journals
Real-World Dupilumab Wins in Treating Refractory EoE
Patients showed endoscopic, histologic, and symptomatic improvement on dupilumab.